DEXAMETHASONE IMPLANT FOR DIABETIC MACULAR EDEMA IN NAIVE COMPARED WITH REFRACTORY EYES: The International Retina Group Real-Life 24-Month Multicenter Study. The IRGREL-DEX Study.

M, Iglicki; C, Busch; D, Zur; M, Okada; M, Mariussi; JK, Chhablani; Z, Cebeci; S, Fraser-Bell; V, Chaikitmongkol; A, Couturier; E, Giancipoli; M, Lupidi; PJ, Rodríguez-Valdés; M, Rehak; AT, Fung; M, Goldstein; A, Loewenstein

doi:10.1097/iae.0000000000002196

Public

DEXAMETHASONE IMPLANT FOR DIABETIC MACULAR EDEMA IN NAIVE COMPARED WITH REFRACTORY EYES: The International Retina Group Real-Life 24-Month Multicenter Study. The IRGREL-DEX Study.

Shared by NobleBlocks on Jan 1, 2019 • 12:00 AM UTC

Authors:

Iglicki M

Busch C

Zur D

Abstract

<h4>Purpose</h4>To investigate efficacy and safety of repeated dexamethasone (DEX) implants over 24 months, in diabetic macular edema (DME) eyes that were treatment naive compared with eyes refractory to anti-vascular endothelial growth factor treatment, in a real-life environment.<h4>Methods</h4>Th...

Discussions